Pokushalov, E.; Ponomarenko, A.; Bayramova, S.; Garcia, C.; Pak, I.; Shrainer, E.; Voronina, E.; Sokolova, E.; Johnson, M.; Miller, R.
Evaluating the Impact of Omega-3 Fatty Acid (SolowaysTM) Supplementation on Lipid Profiles in Adults with PPARG Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2024, 16, 97.
https://doi.org/10.3390/nu16010097
AMA Style
Pokushalov E, Ponomarenko A, Bayramova S, Garcia C, Pak I, Shrainer E, Voronina E, Sokolova E, Johnson M, Miller R.
Evaluating the Impact of Omega-3 Fatty Acid (SolowaysTM) Supplementation on Lipid Profiles in Adults with PPARG Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2024; 16(1):97.
https://doi.org/10.3390/nu16010097
Chicago/Turabian Style
Pokushalov, Evgeny, Andrey Ponomarenko, Sevda Bayramova, Claire Garcia, Inessa Pak, Evgenya Shrainer, Elena Voronina, Ekaterina Sokolova, Michael Johnson, and Richard Miller.
2024. "Evaluating the Impact of Omega-3 Fatty Acid (SolowaysTM) Supplementation on Lipid Profiles in Adults with PPARG Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial" Nutrients 16, no. 1: 97.
https://doi.org/10.3390/nu16010097
APA Style
Pokushalov, E., Ponomarenko, A., Bayramova, S., Garcia, C., Pak, I., Shrainer, E., Voronina, E., Sokolova, E., Johnson, M., & Miller, R.
(2024). Evaluating the Impact of Omega-3 Fatty Acid (SolowaysTM) Supplementation on Lipid Profiles in Adults with PPARG Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 16(1), 97.
https://doi.org/10.3390/nu16010097
